Relative activity (%) SC35M

Size: px
Start display at page:

Download "Relative activity (%) SC35M"

Transcription

1 a 125 Bat (H17N) b 125 A/WSN (H1N1) Relative activity (%) Relative activity (%) Pos. Neg. PA PB1 Pos. Neg. NP PA PB1 PB2 0 Pos. Neg. NP PA PB1 PB2 SC35M Bat Supplementary Figure 1. Functional complementarities of bat and influenza A virus NP. a-b Relative polymerase activity of H17N (a) or WSN/33 (b) determined in HEK293T cells without (Pos.) or after substitution of the indicated single components of the influenza A virus strains A/ SC35M or bat H17N. Omission of the polymerase subunit PB1 (Neg.) served as a negative control. Shown are mean and SD of 3 independent experiments.

2 a CarperAEC.B b NPTr c A SC35M Bat C1 Bat C2 Bat C3 d EpoNi/ SC35M (37 C) SC35M (33 C) Bat C3 (37 C) Bat C3 (33 C) 9 CarperAEC.B SC35M (37 C) SC35M (33 C) Bat C3 (37 C) Bat C3 (33 C) EpoNi/ SC35M (37 C) SC35M (40 C) Bat C3 (37 C) Bat C3 (40 C) 9 CarperAEC.B SC35M (37 C) SC35M (40 C) Bat C3 (37 C) Bat C3 (40 C) Supplementary Figure 2. Viral growth of Bat C1, C2 and C3 in cell cultures. a-c, Bat CarperAEC.B-3 (a), newborn pig trachea (NPTr) (b) or human adenocarcinoma lung (A549) cells (c) were infected with the indicated viruses at an MOI of Shown are mean and SD of 3 independent experiments. d, Bat EpoNi/22.1 and CarperAEC.B-3 cells were infected with Bat C3 or SC35M at an MOI of 0.01 at either 33, 37 C or 40 C. Shown are mean and SD of 3 independent experiments.

3 a BALB/c (lungs) SC35M ( 3 PFU) Bat C1 ( 4 PFU) Bat C3 ( 4 PFU) Days p.i. b BALB/c (nasal turbinates) Bat C1 ( 4 PFU) Bat C3 ( 4 PFU) Days p.i. c 1 BALB/c Body weight (%) Bat C3 ( 6 PFU) Days p.i. d Bat Bat C1 Bat C2 NS C1 C2 C3 C1 C2 C3 B6 B6-STAT1 / Bat C3 NS Bat C1 * Bat C2 Bat C3 Supplementary Figure 3. Viral growth of Bat C1, C2 and C3 in mice. Viral titers in lung (a) and nasal turbinate (b) of BALB/c mice infected with Bat C1 or Bat C3 ( 4 PFU) for the indicated time. c, Weight of BALB/c mice (n=5/group) infected with the indicated viral dose. Shown are mean and SD. d, Viral lung titers (PFU per lung) in B6 or B6- STAT1-/- mice intranasally infected with 4 PFU of Bat C1, C2 and C3 72h post infection. Student s t-test was performed to determine the P value. *P<0.05; NS, not significant.

4 a HEK293T b LMH Relative activity (%) Relative activity (%) Bat+ Bat- PA S550R PB1 E656G Bat+ Bat- PA S550R PB1 E656G Supplementary Figure 4. Avian-adaptive mutations in PB1 and PA enhances viral polymerase activity. The bat polymerase activity was determined in avian LMH or human HEK293T cells in the presence of wt (Bat+), PA S550R or PB1 E656G. Omission of PB1 served as a negative control (Bat-). Shown are mean and SD of 3 independent experiments.

5 Supplementary Figure 5. Protein alignment of M2 host-specific consensus sequences. Protein sequences of M2 proteins of influenza isolates were grouped according to their host and aligned using MUSCLE. The four consensus sequences obtained from the alignments were compared. The consensus sequence is illustrated as sequence logo. Mean pairwise identity over all pairs in the column is given in green (0% identity), brown (at least 30% and under 0% identity) and red (below 30% identity). Transmembrane regions predicted by TMHMM are indicated in greyish bar. Arrow indicates position 31.

6 Supplementary Table 1. Reconstitution and detection of virus-like particles (VLP) using a GFP minigenome. Bat/SC35M HA-NA-3P*-NP-M1-M2-NEP VLP no** no no no no no** no** * 3P = PB2, PB1 and PA ** in the presence or absence of trypsin in the culture medium

7 Supplementary Table 2. Sequence variations observed in Bat C1, C2 and C3 virus stocks prepared in MDCK cells by deep sequencing. Segment Pos Change VarFreq* AA Change Bat C1 1_PB2 99 C>T 11% silent 3_PA 1672 T>G 99% S>R (550) 6_NA 621 G>A 98% V>I (167) Bat C2 2_PB A>G 98% E>G (656) 4_HA 1646 A>G 49% silent 8_NS 177 T>C 30% silent Bat C3 4_HA 34 T>C 0% 3`UTR 4_HA 1307 C>A 58% silent Nucleotides different to the published H17N sequence are highlighted in green. Nucleotide changes that cause amino acid changes are highlighted in orange. * VarFreq, variant frequency

8 Supplementary Table 3. Mutations identified in Bat C1, C2 and C3 after amplification in avian DF-1 cells. Segment Pos Change VarFreq* AA Change Bat C1 7_M2 803 A>G n.d.** N>S (31) 7_M2 919 A>G n.d. T>A (70) Bat C2 4_HA ab 1307 C>T 22 a;30 b% silent 7_M2 ab 802 A>C 22 a;19 b% N>H (31) 7_M1 b 341 G>A 14% silent 7_M1 b 347 T>G 14% silent 7_M1 b 365 A>G 16% silent 7_M1 b 369 G>T 16% A>S (116) 7_M1 a 441 A>G 11% T>A (140) 7_M2 a 803 A>G 15% N>S (31) Bat C3 3_PA 1835 C>T n.d. P>S (605) 4_HA 307 T>C n.d. I>T (59) 7_M1 441 A>G n.d. T>A (140) Bat C1 and C3 mutations were identified by sequencing RT-PCR amplification products. Bat C2 mutations were identified by deep sequencing from two independent virus stocks (a and b). Nucleotide changes are highlighted in pink. Amino acid changes are indicated in orange. * VarFreq, variant frequency; ** n.d., not determined

9 Supplementary Table 4. Sequence variations observed in Bat C1, C2 and C3 virus stocks prepared from eggs infected with MDCK- or DF-1-derived virus stocks by deep sequencing. MDCK-derived virus stock DF-1-derived virus stock Segment Pos Change VarFreq* AA Change Segment Pos Change VarFreq* AA Change Bat C1 4_HA ab 78 G>A 86 a;0 b% R>Q (316) Bat C1 1_PB2 ab 587 A>G 11 a;14 b% K>R (187) 4_HA b 967 A>G 34% D>G (279) 2_PB1 a 1686 G>A 16% D>N (554) 7_M2 a 803 A>G % N>S (31) 4_HA b 966 G>T 11% D>Y (279) 7_M2 a 986 T>C 39% V>A (92) 4_HA a 78 G>A 11% R>Q (316) 4_HA b 1379 A>G 13% silent (416) 4_HA b 1384 A>T 14% Q>L (418) 4_HA b 1386 A>T 13% I>F (419) 6_NA b 858 A>C 11% S>R (246) 6_NA b 861 A>T 12% S>C (247) Bat C2 3_PA ab 1671 G>A 27 b;74 a% S>N (550) Bat C2 4_HA ab 1307 C>T 61 a;66 b% silent (392) 4_HA ab 179 T>C 12 b;64 a% silent (16) 7_M2 ab 802 A>G 29 a;39 b% N> H (31) 4_HA ab 78 G>A 32 b;88 a% R>Q (316) 7_M2 ab 803 A>G 53 b;64 a% N>S (31) 4_HA b 1301 C>T 15% silent (390) 7_M2 ab 904 A>G 11 b;29 a% R>G (65) 4_HA b 1307 C>T 15% silent (392) 7_M2 ab 930 A>G 11 b;30 a% silent (73) 8_NS1 b 676 G>T 11% D>Y (217) 2_PB1 a 92 T>A 13% F>L (22) 8_NEP b 676 G>T 11% K>N (58) 7_M a 04 A>T 14% 5`UTR Bat C3 3_PA b 565 A>G 30% silent (181) Bat C3 5_NP a 639 T>G 13% M>R (200) 4_HA b 1153 G>A 43% R>Q (341) 7_M2 a 802 A>C 19% N>H (31) 6_NA a 824 A>G 40% silent (234) Nucleotide changes are highlighted in purple. Amino acid changes are highlighted in orange. Sequences were determined from two infected eggs (a and b) with highest titer. * VarFreq, variant frequency

10 Supplementary Table 5. Rescue attempts of Bat H17N and SC35M reassortant viruses by reverse genetics using authentic genome segments. Bat H17N SC35M Rescue 3P*, M, NP, HA, NA, NS no 3P, M, NP, HA, NA NS no 3P, M, NP, NS HA, NA no 3P, NP, NS HA, NA, M no 3P, NP HA, NA, M, NS no M, NS HA, NA, 3P, NP no NP HA, NA, 3P, M, NS no M HA, NA, 3P, NP, NS no NS HA, NA, 3P, NP, M no PB2 HA, NA, 2P**, NP, M, NS no HA, NA, 3P, NP, M, NS * 3P = PB2, PB1 and PA ** 2P = PB1 and PA

11 Supplementary Table 6. Reassortment events after co-infection of MDCKII cells. Strain Initial infection dose (MOI) Number of clones Number of parental strains Reassortment events Bat C3:SC35M 1: * 48 Bat C3 / 44 SC35M 0 Bat C3:WSN 1: Bat C3 / 2 WSN 0 Bat C3:WSN 1: Bat C3 / 27 WSN 0 Bat C3:WSN 1:1 0 3 Bat C3 / 97 WSN 0 SC35M:WSN 1:1 0 0 SC35M / 95 WSN 5 * after analysis, 6 clones contained a mixture of both parental viruses, but no segment reassortment.

12 Supplementary Table 7. A list of primers used to identify strain specific genome segments in reassortment experiments. WSN vs SC35M PB2-F WSN GCACAGGATGTAATCATGGAAGT PB2-R WSN CAGTTCTCTCTCCAACATGTATGC SC35M GCACAGGATGTAATCATGGAAGT SC35M ACCAATTCTCTTTCTAGCATGTATGC PB1-F WSN CTAATTAGGGCATTAACCCTGAACACAATGAC PB1-R WSN ACAAACCCCCTTATTTGCATCCC SC35M CTAATAAGAGCATTGACACTGAACACAATGAC SC35M ACAAATCCTCTGATTTGCATCCC PA-F WSN GGGGAGGAAATGGCCAC PA-R WSN CTGACGAAAGGAATCCCAGAG SC35M ACTGGAGAAGAAATGGCCAC SC35M GATTGACGAAAGGAATCCCAGAG HA-F WSN TCTATTTGGAGCCATTGCTGG HA-R WSN TGCTTTTTTGATCCGCTGCA SC35M GCTTTTGGGAGCAATTGCTGG SC35M GTGCTTTTGTAGTCAGCTGCA NP-F WSN CTTTGAAAGAGAGGGATACTCTCTAGT NP-975-R WSN CTGTTTTGAAGCAGTCTGAAAGGG SC35M GAGAGAGAGGGATACTCCCTAGT SC35M CTGTTTTGGAGCAGGCGGAAAG NA-F WSN GTTCCAGACATGGGTTTGAGATG NA-R WSN TCCGCTGTACCCTGACC SC35M cgttccagaagtggttttgagatg SC35M AAACTCCCTGAGTATCCTGACC M-F WSN GATAACATTCCATGGGGCCAA M-R WSN GCCACTTCAGTGGTCACAG SC35M GAAATTACATTCCATGGGGCCAA SC35M CCACTTCGGTGGTCACAG NS-F WSN GGACCAGGCGATCATGGATAA NS-R WSN TGTCCCCTCTTCGGTGAA WSN vs Bat C3 SC35M GGACCAGGCGATCATGGATAA SC35M CAATTGCTCCTTCTTCGGTGAA PB2-F WSN GCACAGGATGTAATCATGGAAGT PB2-R WSN CAGTTCTCTCTCCAACATGTATGC Bat GGCACAAGAAGTCATTATGGAAGT Bat TTCCCTTTCCAGCATGTATGC PB1-F WSN TGATGGGCATGTTCAATATGTTAAGTAC PB1-R WSN AGATTGAAGACCATCCCACCA Bat ATGATGGGAATGTTCAATATGCTTAGTAC Bat GGAGGCCATCCCACCA PA-F WSN CACAAATGGGAGAAGTACTGTGTTCTTGA PA-R WSN CTCATTTCCATCCCCCATTTCATTTT Bat CATAAGTGGGAGAAATACTGCGTACTAGA Bat CTCATTTCCATTCCCCATTTCATTTT HA-F WSN TCTATTTGGAGCCATTGCTGG HA-R WSN TGCTTTTTTGATCCGCTGCA (same as WSN/SC35M) Bat GCTTTTGGGAGCAATTGCTGG Bat GTGCTTTTGTAGTCAGCTGCA NP-F WSN GACATGAGAACCGAAATCATAAGGCTGATGGAAA NP-R WSN ACTCCTCTGCATTGTCTCCGAAGAAATAAGA Bat GACATGAGGACTGAAATAATCAGACTTATGGAAA Bat ACTCGTCTGCCTTGTCTCCAAAGAAATAAGA NA-F WSN GTTCCAGACATGGGTTTGAGATG NA-R WSN TCCGCTGTACCCTGACC (same as WSN/SC35M) SC35M cgttccagaagtggttttgagatg SC35M AAACTCCCTGAGTATCCTGACC M-F WSN GATAACATTCCATGGGGCCAA M-R WSN GCCACTTCAGTGGTCACAG Bat GATAACTTTCCATGGGGCCAA Bat GCCACTTCGGTTGTCACAG NS-F WSN GGACCAGGCGATCATGGATAA NS-R WSN TGTCCCCTCTTCGGTGAA SC35M vs Bat C3 Bat CATGGACCAAGCAGTAACCAATAA Bat ACTACTGTCCCTTCTTCTGTGAA PB2-F SC35M GCACAGGATGTAATCATGGAAGT PB2-R SC35M ACCAATTCTCTTTCTAGCATGTATGC Bat GGCACAAGAAGTCATTATGGAAGT Bat TTCCCTTTCCAGCATGTATGC PB1-F SC35M CTAATAAGAGCATTGACACTGAACACAATGAC PB1-R SC35M ACAAATCCTCTGATTTGCATCCC Bat CTAATAAGGGCACTGACCCTAAATACAATGAC Bat ACAAACCCTCTAATTTGCATCCC PA-F SC35M CACAAGTGGGAGAAGTATTGTGTCCTTGA PA-R SC35M CTCATTTCCATACCCCATTTCATTTT Bat CATAAGTGGGAGAAATACTGCGTACTAGA Bat CTCATTTCCATTCCCCATTTCATTTT 2HA-F SC35M AGCAGAAGCAGGGTCACTATTAC HA-common-R ATGGTGTCCAAGACATATTTTGTCTCC Bat AGCAAAAGCAGGGGATACAAAATG NP-F SC35M GAGAGAGAGGGATACTCCCTAGT NP-R13-41 SC35M TCCATACCAGTTGACTTTTATGTGC Bat ACTTTGAAAAAGAGGGATACTCTCTAGT Bat ACACTAGCTGACTTTTGTGTGC 2NA-F SC35M AGCAGAAGCAGGAGTTTTTAATAAAGTC NA-common-R CTTTAAGTGTAATGAGACATTCAGCACC Bat AGCAAAAGCAGGGTGATTGAG M-F SC35M GAAATTACATTCCATGGGGCCAA M-R SC35M CCACTTCGGTGGTCACAG Bat GATAACTTTCCATGGGGCCAA Bat GCCACTTCGGTTGTCACAG NS-F SC35M GGACCAGGCGATCATGGATAA NS-R SC35M CAATTGCTCCTTCTTCGGTGAA *Fluorescent probes PB2 Bat CATGGACCAAGCAGTAACCAATAA Bat ACTACTGTCCCTTCTTCTGTGAA [6FAM]-GAGCCAGGATACTAACATCGGAATCGCAAC-[BHQ1] M [6FAM]-AAGAAATAGCATTCAGTTATTCTGC-[BHQ1] NS [6FAM]-GTGATTTTTGACCGGCTGGAGACTC-[BHQ1] * In the indicated combinations we used a fluorescent probe with Light Cycler 480 genotyping master buffer (Roche) and manufacturer recommended conditions.

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid.

Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Supplementary Figure 1. SC35M polymerase activity in the presence of Bat or SC35M NP encoded from the phw2000 rescue plasmid. HEK293T

More information

Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E,

Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, Supplementary Figure 1. FACS analysis of cells infected with TY93/H5N1 GFP-627E, TY93/H5N1 GFP-627K, or the TY93/H5N1 PB2(588-759) virus library. To establish our GFP- FACS screening platform, we compared

More information

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with

Supplementary Figure 1 Weight and body temperature of ferrets inoculated with Supplementary Figure 1 Weight and body temperature of ferrets inoculated with A/Anhui/1/2013 (H7N9) influenza virus. (a) Body temperature and (b) weight change of ferrets after intranasal inoculation with

More information

Supplementary Figure 1. Prevalence of U539C and G540A nucleotide and E172K amino acid substitutions among H9N2 viruses. Full-length H9N2 NS

Supplementary Figure 1. Prevalence of U539C and G540A nucleotide and E172K amino acid substitutions among H9N2 viruses. Full-length H9N2 NS Supplementary Figure 1. Prevalence of U539C and G540A nucleotide and E172K amino acid substitutions among H9N2 viruses. Full-length H9N2 NS nucleotide sequences (a, b) or amino acid sequences (c) from

More information

Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent Protein.

Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent Protein. prfp-vector RFP Exon1 Intron RFP Exon2 prfp-mir-124 mir-93/124 RFP Exon1 Intron RFP Exon2 Untransfected prfp-vector prfp-mir-93 prfp-mir-124 Supplementary Fig. 1. Delivery of mirnas via Red Fluorescent

More information

Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host

Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host Cell Host & Microbe, Volume 16 Supplemental Information Influenza A Virus Transmission Bottlenecks Are Defined by Infection Route and Recipient Host Andrew Varble, Randy A. Albrecht, Simone Backes, Marshall

More information

Supplementary Figure 1 Schematic overview of the mutant virus libraries and their

Supplementary Figure 1 Schematic overview of the mutant virus libraries and their Supplementary Figure 1 Schematic overview of the mutant virus libraries and their consecutive passages in MDCK cells. All nine virus libraries were passaged twice in MDCK cells. Then, aliquots of all nine

More information

Nature Medicine: doi: /nm.4322

Nature Medicine: doi: /nm.4322 1 2 3 4 5 6 7 8 9 10 11 Supplementary Figure 1. Predicted RNA structure of 3 UTR and sequence alignment of deleted nucleotides. (a) Predicted RNA secondary structure of ZIKV 3 UTR. The stem-loop structure

More information

Development of safe and immunogenic reassortant viruses with 5:3 genotype for live attenuated influenza vaccine

Development of safe and immunogenic reassortant viruses with 5:3 genotype for live attenuated influenza vaccine Development of safe and immunogenic reassortant viruses with 5:3 genotype for live attenuated influenza vaccine Irina Isakova-Sivak, PhD Institute of Experimental Medicine, Saint Petersburg, Russia The

More information

FIG S1 Examination of eif4b expression after virus infection. (A) A549 cells

FIG S1 Examination of eif4b expression after virus infection. (A) A549 cells Supplementary Figure Legends FIG S1 Examination of expression after virus infection. () 549 cells were infected with herpes simplex virus (HSV) (MOI = 1), and harvested at the indicated times, followed

More information

To test the possible source of the HBV infection outside the study family, we searched the Genbank

To test the possible source of the HBV infection outside the study family, we searched the Genbank Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),

More information

Synthetic Genomics and Its Application to Viral Infectious Diseases. Timothy Stockwell (JCVI) David Wentworth (JCVI)

Synthetic Genomics and Its Application to Viral Infectious Diseases. Timothy Stockwell (JCVI) David Wentworth (JCVI) Synthetic Genomics and Its Application to Viral Infectious Diseases Timothy Stockwell (JCVI) David Wentworth (JCVI) Outline Using informatics to predict drift (strain selection) Synthetic Genomics: Preparedness

More information

NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar

NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY. 16th International WAVLD symposium, 10th OIE Seminar NEXT GENERATION SEQUENCING OPENS NEW VIEWS ON VIRUS EVOLUTION AND EPIDEMIOLOGY S. Van Borm, I. Monne, D. King and T. Rosseel 16th International WAVLD symposium, 10th OIE Seminar 07.06.2013 Viral livestock

More information

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication

Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Oscar Blanch-Lombarte Rome, 7-9 June, 2017 European

More information

Supplementary materials

Supplementary materials Supplementary materials Chemical library from ChemBridge 50,240 structurally diverse small molecule compounds dissolved in DMSO Hits Controls: No virus added μ Primary screening at 20 g/ml of compounds

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature14008 Supplementary Figure 1. Sequence alignment of A/little yellow-shouldered bat/guatemala/060/2010 (H17N10) polymerase with that of human strain A/Victoria/3/75(H3N2). The secondary

More information

Envelope e_ :------, Envelope glycoproteins e_ ~ Single-stranded RNA ----, Nucleocapsid

Envelope e_ :------, Envelope glycoproteins e_ ~ Single-stranded RNA ----, Nucleocapsid Virus Antib(tdies Your Expertise, Our Antibodies, Accelerated Discovery. Envelope e_---------:------, Envelope glycoproteins e_-------1~ Single-stranded RNA ----, Nucleocapsid First identified in 1989,

More information

Phylogenetic analysis of human and chicken importins. Only five of six importins were studied because

Phylogenetic analysis of human and chicken importins. Only five of six importins were studied because Supplementary Figure S1 Phylogenetic analysis of human and chicken importins. Only five of six importins were studied because importin-α6 was shown to be testis-specific. Human and chicken importin protein

More information

modified dye uptake assay including formazan test EC 90 not tested plaque reduction assay

modified dye uptake assay including formazan test EC 90 not tested plaque reduction assay Sauerbrei A, Bohn-Wippert K, Kaspar M, Krumbholz A, Karrasch M, Zell R. 2015. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes

More information

Reassortment of influenza A virus genes linked to PB1 polymerase gene

Reassortment of influenza A virus genes linked to PB1 polymerase gene International Congress Series 1263 (2004) 714 718 Reassortment of influenza A virus genes linked to PB1 polymerase gene Jean C. Downie* www.ics-elsevier.com Centre for Infectious Diseases and Microbiology,

More information

Supplementary Fig. S1. Schematic diagram of minigenome segments.

Supplementary Fig. S1. Schematic diagram of minigenome segments. open reading frame 1565 (segment 5) 47 (-) 3 5 (+) 76 101 125 149 173 197 221 246 287 open reading frame 890 (segment 8) 60 (-) 3 5 (+) 172 Supplementary Fig. S1. Schematic diagram of minigenome segments.

More information

33VASTVNGATSANNHGEPPS51PADARPR58

33VASTVNGATSANNHGEPPS51PADARPR58 Pro-rich region Trans-membrane region 214 246 359 381 UL50 1 397 211SSRTAS216PPPPPR222 NLS CR1 CR2 CR3 CR4 UL53 1 376 11RERRS15ALRS19LLRKRRR25 33VASTVNGATSANNHGEPPS51PADARPR58 FIG S1. UL97 phosphorylation

More information

Influenza Genome Sequencing Project Proposal

Influenza Genome Sequencing Project Proposal Date of Proposal (MM/DD/YY): 06/13/12 TITLE: Role of the Untranslated Regions of the Influenza A Virus Replication and Vaccines Purpose/Objective-please provide a brief one to two paragraph description

More information

Importance of 1918 virus reconstruction on current assessments to pandemic risk

Importance of 1918 virus reconstruction on current assessments to pandemic risk Importance of 1918 virus reconstruction on current assessments to pandemic risk Jessica A Belser, PhD Immunology and Pathogenesis Branch Influenza Division Centers for Disease Control and Prevention National

More information

Multifunctional Adaptive NS1 Mutations Are Selected upon Human Influenza Virus Evolution in the Mouse

Multifunctional Adaptive NS1 Mutations Are Selected upon Human Influenza Virus Evolution in the Mouse Multifunctional Adaptive NS1 Mutations Are Selected upon Human Influenza Virus Evolution in the Mouse Nicole E. Forbes 1,2, Jihui Ping 1,2, Samar K. Dankar 1,2, Jian-Jun Jia 1,2, Mohammed Selman 1,2, Liya

More information

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses

Impact of Amino Acid Mutations in PB2, PB1-F2, and NS1 on the Replication and Pathogenicity of Pandemic (H1N1) 2009 Influenza Viruses JOURNAL OF VIROLOGY, May 2011, p. 4596 4601 Vol. 85, No. 9 0022-538X/11/$12.00 doi:10.1128/jvi.00029-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Impact of Amino Acid Mutations

More information

Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus

Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus Iranian Journal of Virology 2011;5(4): 6-10 2011, Iranian Society for Virology Original Article Development and Sequence Analysis of a Cold-Adapted Strain of Influenza A/New Caledonia/20/1999(H1N1) Virus

More information

Cristina Cassetti, Ph.D.

Cristina Cassetti, Ph.D. NIAID Extramural Research Update: Recombinant Influenza Viruses and Biosafety Cristina Cassetti, Ph.D. Influenza Program Officer Division of Microbiology and Infectious Diseases NIAID Influenza virus DMID

More information

Diagnosis of H1N1 (2009) at the CSIRO Australian Animal Health Laboratory

Diagnosis of H1N1 (2009) at the CSIRO Australian Animal Health Laboratory Diagnosis of H1N1 (2009) at the CSIRO Australian Animal Health Laboratory Peter Daniels and Paul Selleck Prepared for the 2 nd OFFLU Technical Meeting OIE Paris, 15 & 16 September, 2009 AAHL holds the

More information

Study the Evolution of the Avian Influenza Virus

Study the Evolution of the Avian Influenza Virus Designing an Algorithm to Study the Evolution of the Avian Influenza Virus Arti Khana Mentor: Takis Benos Rachel Brower-Sinning Department of Computational Biology University of Pittsburgh Overview Introduction

More information

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR

Supplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4

More information

WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update

WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines: Update 23 July 2009 Introduction This document updates guidance 1 from the World

More information

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan

Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan International Congress Series 1263 (2004) 749 753 Existence of reassortant A (H1N2) swine influenza viruses in Saitama Prefecture, Japan Shin ichi Shimada a, *, Takayasu Ohtsuka b, Masayuki Tanaka b, Munehito

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION doi:10.1038/nature10831 1. Pathological analyses of H5 avian-human reassortant viruses. The rgca04 infection in the lungs of ferrets mainly caused severe bronchopneumonia with

More information

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA

Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA Meng et al. Virology Journal (2017) 14:138 DOI 10.1186/s12985-017-0805-6 RESEARCH Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA Open Access Bo Meng

More information

Unité de Génétique Moléculaire des Virus Respiratoires, URA 1966 CNRS, Institut Pasteur, 25 rue du Dr. Roux, PARIS Cedex 15, France

Unité de Génétique Moléculaire des Virus Respiratoires, URA 1966 CNRS, Institut Pasteur, 25 rue du Dr. Roux, PARIS Cedex 15, France Virology 345 (2006) 73 87 www.elsevier.com/locate/yviro Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5V terminal sequence: Induction of heterospecific

More information

From Mosquitos to Humans: Genetic evolution of Zika Virus

From Mosquitos to Humans: Genetic evolution of Zika Virus Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical

More information

Animal hosts Natural host Laboratory animals Rabbits Mice Rats Hamsters Newborn or suckling rodents Animal models for viral pathogenesis 4 Growth of v

Animal hosts Natural host Laboratory animals Rabbits Mice Rats Hamsters Newborn or suckling rodents Animal models for viral pathogenesis 4 Growth of v Principles of Virology Department of Molecular Genetics & Microbiology Univ ersity of Florida, Gainesv ille, FL 1 Outline Virus cultivation Assay of viruses Virus genetics 2 Virus isolation Evidence of

More information

HCV NS3 Protease Drug Resistance

HCV NS3 Protease Drug Resistance test code: cpt code: 10000 87902 category: Infectious Disease HCV genotype 1a CODON Glecaprevir 1a Grazoprevir 1a Paritaprevir 1a Simeprevir 1a Voxilaprevir 1a V36A S 13 R 10 Comment V36C V36G V36I V36L

More information

Flu, Avian Flu and emerging aspects (H1N1 resistance)

Flu, Avian Flu and emerging aspects (H1N1 resistance) EU-CIS Seminar New trends in Infectious Diseases 26 28 November 2008 / Lyon, France Flu, Avian Flu and emerging aspects (H1N1 resistance) Pr. Florence MORFIN FRE 3011 Université Lyon 1 - CNRS Laboratory

More information

Evolution of influenza

Evolution of influenza Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal

More information

Phylogenetic Methods

Phylogenetic Methods Phylogenetic Methods Multiple Sequence lignment Pairwise distance matrix lustering algorithms: NJ, UPM - guide trees Phylogenetic trees Nucleotide vs. amino acid sequences for phylogenies ) Nucleotides:

More information

Lecture 19 Evolution and human health

Lecture 19 Evolution and human health Lecture 19 Evolution and human health The evolution of flu viruses The evolution of flu viruses Google Flu Trends data US data Check out: http://www.google.org/flutrends/ The evolution of flu viruses the

More information

Evaluation of real time PCR reagents for detection of influenza A virus RNA CAHLN 2017 June 7th 2017, Kristin Mesires, Ph.D.

Evaluation of real time PCR reagents for detection of influenza A virus RNA CAHLN 2017 June 7th 2017, Kristin Mesires, Ph.D. Evaluation of real time PCR reagents for detection of influenza A virus RNA CAHLN 2017 June 7th 2017, Kristin Mesires, Ph.D. 2017 IDEXX Laboratories, Inc. All rights reserved. Agenda Overview of the RealPCR

More information

Application of Reverse Genetics to Influenza Vaccine Development

Application of Reverse Genetics to Influenza Vaccine Development NIAID Application of Reverse Genetics to Influenza Vaccine Development Kanta Subbarao Laboratory of Infectious Diseases NIAID, NIH Licensed Vaccines for Influenza Principle: Induction of a protective

More information

Modeling the Antigenic Evolution of Influenza Viruses from Sequences

Modeling the Antigenic Evolution of Influenza Viruses from Sequences Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.

More information

OFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine. OIE headquarters, Paris, France March 27-28, 2012

OFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine. OIE headquarters, Paris, France March 27-28, 2012 OFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine OIE headquarters, Paris, France March 27-28, 2012 Brazil update Janice Reis Ciacci Zanella Brazilian Agricultural Research

More information

Experiences with Live Attenuated Avian Influenza Vaccine Trials in Thailand

Experiences with Live Attenuated Avian Influenza Vaccine Trials in Thailand Experiences with Live Attenuated Avian Influenza Vaccine Trials in Thailand Punnee Pitisuttithum, MBBS,DTM&H,FRCPT Vaccine Trial Center,Faculty of Tropical Medicine, Mahidol University For MOPH,CDC,MU,Geneva

More information

Infection dynamics of novel influenza A viruses isolated from Australian pigs

Infection dynamics of novel influenza A viruses isolated from Australian pigs Infection dynamics of novel influenza A viruses isolated from Australian pigs Joanne Taylor PhD Candidate Supervisors: Dr Frank Wong, Dr David Williams, Dr John Bingham, Dr Joanne Meers 3 rd December 2015

More information

Supplementary Figure 1

Supplementary Figure 1 Count Count Supplementary Figure 1 Coverage per amplicon for error-corrected sequencing experiments. Errorcorrected consensus sequence (ECCS) coverage was calculated for each of the 568 amplicons in the

More information

Plasmid-Driven Formation of Influenza Virus-Like Particles

Plasmid-Driven Formation of Influenza Virus-Like Particles JOURNAL OF VIROLOGY, Jan. 2000, p. 547 551 Vol. 74, No. 1 0022-538X/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Plasmid-Driven Formation of Influenza Virus-Like

More information

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester

DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview

More information

Influenza antiviral susceptibility: methods and challenges to detect resistant virus

Influenza antiviral susceptibility: methods and challenges to detect resistant virus SARINet Pan-American Health Organization - PAHO Influenza antiviral susceptibility: methods and challenges to detect resistant virus Brazilian experience Paola Cristina Resende, PhD Researcher National

More information

Characterization of Uncultivable Bat Influenza Virus Using a Replicative Synthetic Virus

Characterization of Uncultivable Bat Influenza Virus Using a Replicative Synthetic Virus Characterization of Uncultivable Bat Influenza Virus Using a Replicative Synthetic Virus Bin Zhou 1. a, Jingjiao Ma 2., Qinfang Liu 2., Bhupinder Bawa 2, Wei Wang 1, Reed S. Shabman 1, Michael Duff 2,

More information

Differential Localization and Function of PB1-F2 Derived from Different Strains of Influenza A Virus

Differential Localization and Function of PB1-F2 Derived from Different Strains of Influenza A Virus JOURNAL OF VIROLOGY, Oct. 2010, p. 10051 10062 Vol. 84, No. 19 0022-538X/10/$12.00 doi:10.1128/jvi.00592-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Differential Localization

More information

Reverse genetic platform for inactivated and live-attenuated influenza vaccine

Reverse genetic platform for inactivated and live-attenuated influenza vaccine EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 42, No. 2, 116-121, February 2010 Reverse genetic platform for inactivated and live-attenuated influenza vaccine Eun-Ju Jung, Kwang-Hee Lee and Baik Lin Seong

More information

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences

Avian Influenza Virus H7N9. Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus H7N9 Dr. Di Liu Network Information Center Institute of Microbiology Chinese Academy of Sciences Avian Influenza Virus RNA virus, Orthomyxoviruses Influenza A virus Eight Gene segments

More information

Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses

Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses Risk Assessment of H3N2 Avian Origin Canine Influenza Viruses Henry Wan, Ph.D. Department of Basic Sciences College of Veterinary Medicine Mississippi State University E-mail: wan@cvm.msstate.edu Phone:

More information

ph1n1 H3N2: A Novel Influenza Virus Reassortment

ph1n1 H3N2: A Novel Influenza Virus Reassortment ph1n1 H3N2: A Novel Influenza Virus Reassortment Jonathan Gubbay Medical Microbiologist Public Health Laboratory Public Health Ontario June 16, 2011 ph1n1 H3N2 Reassortment: Talk Overview Explain strain

More information

Influenza virus exploits tunneling nanotubes for cell-to-cell spread

Influenza virus exploits tunneling nanotubes for cell-to-cell spread Supplementary Information Influenza virus exploits tunneling nanotubes for cell-to-cell spread Amrita Kumar 1, Jin Hyang Kim 1, Priya Ranjan 1, Maureen G. Metcalfe 2, Weiping Cao 1, Margarita Mishina 1,

More information

Targeted disruption of influenza A virus hemagglutinin in genetically modified. mice reduces viral replication and improves disease outcome

Targeted disruption of influenza A virus hemagglutinin in genetically modified. mice reduces viral replication and improves disease outcome Supplementary Information Targeted disruption of influenza A virus hemagglutinin in genetically modified mice reduces viral replication and improves disease outcome Song Wang 1#, Chao Chen 1#, Zhou Yang

More information

HCV NS3 Protease Drug Resistance

HCV NS3 Protease Drug Resistance test code: cpt code: 10000 87902 category: Infectious Disease HCV genotypes 1a CODON Simeprevir 1a Boceprevir 1a Telaprevir 1a Paritaprevir 1a Grazoprevir 1a V36A Comment R 3 R 10, 11 R 16 S 24 V36C V36G

More information

Section D. Identification of serotype-specific amino acid positions in DENV NS1. Objective

Section D. Identification of serotype-specific amino acid positions in DENV NS1. Objective Section D. Identification of serotype-specific amino acid positions in DENV NS1 Objective Upon completion of this exercise, you will be able to use the Virus Pathogen Resource (ViPR; http://www.viprbrc.org/)

More information

Passive surveillance of swiavs in France

Passive surveillance of swiavs in France SIV group technical meeting Paris, December 3 rd -4 th 2015 Passive surveillance of swiavs in France Gaëlle Simon Swine Virology Immunology Unit National Reference Laboratory for Swine Influenza Ploufragan,

More information

Influence of Host Cell Defence during Influenza Vaccine Production in MDCK Cells

Influence of Host Cell Defence during Influenza Vaccine Production in MDCK Cells Vaccine Technology III, 07 June 2010 Puerto Vallarta/Mexico Influence of Host Cell Defence during Influenza Vaccine Production in MDCK Cells T. Frensing 1, C. Seitz 1, B. Heynisch 2 and U. Reichl 1/2 1

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature12391 Table 1. Binding of A(H7N9) viruses to individual glycan structures. # Structure a Anhui1 Shanghai1 1 Neu5Acα nb nb 2 Neu5Acα ++ nb 3 Neu5Acβ nb nb 4 Neu5Acα2-3(6-O-Su)Galβ1-4GlcNAcβ

More information

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood

Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood tree illustrating CRF01_AE gp120 protein sequence relationships between 107 Envs sampled in the RV144 trial

More information

Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication

Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication Manuscript EMBO-2010-74756 Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication Tsai-Ling Liao, Chung-Yi Wu, Wen-Chi Su, King-Song Jeng and Michael Lai Corresponding

More information

Influenza Virus Reassortment Occurs with High Frequency in the Absence of Segment Mismatch

Influenza Virus Reassortment Occurs with High Frequency in the Absence of Segment Mismatch Influenza Virus Reassortment Occurs with High Frequency in the Absence of Segment Mismatch Nicolle Marshall, Emory University Lalita Priyamvada, Emory University Zachary Ende, Emory University John Steel,

More information

Supporting Information

Supporting Information Supporting Information Yen et al. 10.1073/pnas.1111000108 SI Materials and Methods Cells. Madin Darby canine kidney (MDCK) cells and human embryonic kidney 293T cells were obtained from the American Type

More information

ISG15 sirna # Ctrl sirna+ifn+wt. Virus titer (Pfu/ml) hours post infection. d USP18 sirna #2 IFN

ISG15 sirna # Ctrl sirna+ifn+wt. Virus titer (Pfu/ml) hours post infection. d USP18 sirna #2 IFN a ISG15 sirna Ctrl #1 #2 ISG15 conjugates IB: ISG15 Virus titer (Pfu/ml) b ISG15 sirna #2 10 7 Ctrl sirna+ifn+wt Ctrl sirna+ifn+67 10 6 ISG15 sirna+ifn+wt ISG15 sirna+ifn+67 10 5 10 4 10 3 Free ISG15 10

More information

Nature Immunology: doi: /ni Supplementary Figure 1. Infection strategy.

Nature Immunology: doi: /ni Supplementary Figure 1. Infection strategy. Supplementary Figure 1 Infection strategy. To test the antibody responses against influenza viruses, animals were sequentially infected with two divergent strains of the same subtype. For H1N1 infections,

More information

Preparing for the Fall Flu Season. Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP

Preparing for the Fall Flu Season. Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP Preparing for the Fall Flu Season Laboratory Perspective Jonathan Gubbay Medical Microbiologist Public Health Laboratory OAHPP September 21, 2009 Objectives 1. Review the emergence of Novel Influenza A

More information

The A(H7N9) influenza outbreak in China

The A(H7N9) influenza outbreak in China Viruses in May, Katoomba, 9 11 May 2013 The A(H7N9) influenza outbreak in China Anne Kelso Director WHO Collaborating Centre for Reference and Research on Influenza Melbourne Influenza in the 21 st century:

More information

Sponsors. Production Assistants Steven Claas Lynn Leary. Layout David Brown

Sponsors. Production Assistants Steven Claas Lynn Leary. Layout David Brown Sponsors University of Minnesota College of Veterinary Medicine College of Agricultural, Food and Environmental Sciences Extension Service Swine Center Production Assistants Steven Claas Lynn Leary Layout

More information

Technology Overview. Summary

Technology Overview. Summary Live Attenuated Influenza Vaccines with Altered NS1 Technology Overview Summary Transformative Technology: Live attenuated influenza vaccines (LAIVs) with precise, genetically stable truncations of the

More information

A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza A and the Novel Influenza A(H1N1) Strain

A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza A and the Novel Influenza A(H1N1) Strain Viruses 2009, 1, 1204-1208; doi:10.3390/v1031204 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Article A Novel Duplex Real-Time Reverse-Transcription PCR Assay for the Detection of Influenza

More information

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics

Influenza viruses. Virion. Genome. Genes and proteins. Viruses and hosts. Diseases. Distinctive characteristics Influenza viruses Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics Virion Enveloped particles, quasi-spherical or filamentous Diameter 80-120 nm Envelope is derived

More information

Understanding mortality from pandemic and seasonal influenza

Understanding mortality from pandemic and seasonal influenza Understanding mortality from pandemic and seasonal influenza Jonathan A. McCullers Associate Member Department of Infectious Diseases St. Jude Children s Research Hospital H1 H2 H3 H4 H5 H6 H7 H8 H9 H10

More information

Live Attenuated Influenza Vaccine. I. Background and Seasonal Vaccine

Live Attenuated Influenza Vaccine. I. Background and Seasonal Vaccine Live Attenuated Influenza Vaccine I. Background and Seasonal Vaccine Influenza infection stimulates multiple arms of the immune system Systemic antibody to HA and NA, and multiple internal proteins Mucosal

More information

Influenza A Virus Polymerase Is a Site for Adaptive Changes During Experimental. Primate Research Center, Madison, Wisconsin, USA

Influenza A Virus Polymerase Is a Site for Adaptive Changes During Experimental. Primate Research Center, Madison, Wisconsin, USA JVI Accepts, published online ahead of print on 20 August 2014 J. Virol. doi:10.1128/jvi.01857-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 Influenza

More information

Supplementary information

Supplementary information Supplementary information Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study Juan Wen, Ci

More information

The Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE

The Infectious Cycle. Lecture 2 Biology W3310/4310 Virology Spring You know my methods, Watson --SIR ARTHUR CONAN DOYLE The Infectious Cycle Lecture 2 Biology W3310/4310 Virology Spring 2016 You know my methods, Watson --SIR ARTHUR CONAN DOYLE The Infectious Cycle Virologists divide the infectious cycle into steps to facilitate

More information

INFLUENZA IN SWINE HERDS FOLLOWING THE INTRODUCTION OF PANDEMIC 2009 H1N1

INFLUENZA IN SWINE HERDS FOLLOWING THE INTRODUCTION OF PANDEMIC 2009 H1N1 INFLUENZA IN SWINE HERDS FOLLOWING THE INTRODUCTION OF PANDEMIC 2009 H1N1 Janice Reis Ciacci Zanella PAHO Webinar December 18, 2015 INFLUENZA IN SWINE IN BRAZIL Janice Reis Ciacci Zanella Brazilian Agricultural

More information

Supplementary Figure 1 Validation of Per2 deletion in neuronal cells in N Per2 -/- mice. (a) Western blot from liver extracts of mice held under ad

Supplementary Figure 1 Validation of Per2 deletion in neuronal cells in N Per2 -/- mice. (a) Western blot from liver extracts of mice held under ad Supplementary Figure 1 Validation of Per2 deletion in neuronal cells in N Per2 -/- mice. (a) Western blot from liver extracts of mice held under ad libitum conditions detecting PER2 protein in brain and

More information

Instructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN

Instructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN Instructions for Use RealStar Influenza Screen & Type RT-PCR Kit 4.0 05/2017 EN RealStar Influenza Screen & Type RT-PCR Kit 4.0 For research use only! (RUO) 164003 INS-164000-EN-S01 96 05 2017 altona

More information

Vaccine 30 (2012) Contents lists available at SciVerse ScienceDirect. Vaccine. jou rn al h om epa ge:

Vaccine 30 (2012) Contents lists available at SciVerse ScienceDirect. Vaccine. jou rn al h om epa ge: Vaccine 30 (2012) 7395 7399 Contents lists available at SciVerse ScienceDirect Vaccine jou rn al h om epa ge: www.elsevier.com/locate/vaccine Possible outcomes of reassortment in vivo between wild type

More information

Ali Alabbadi. Bann. Bann. Dr. Belal

Ali Alabbadi. Bann. Bann. Dr. Belal 31 Ali Alabbadi Bann Bann Dr. Belal Topics to be discussed in this sheet: Particles-to-PFU Single-step and multi-step growth cycles Multiplicity of infection (MOI) Physical measurements of virus particles

More information

Influenza A viruses Detection with real time RT-PCR reagents

Influenza A viruses Detection with real time RT-PCR reagents Influenza A viruses Detection with real time RT-PCR reagents Overview:... 1 Products... 2 Influenza A matix FAM-BHQ1 PP500 0.055ml... 2 Influenza A Plasmid 200 pg/ml PLAS500 0.25ml... 2 Detection Influenza

More information

Production of Avian Influenza H5N1 Virus Using the TideCell Bioreactor System

Production of Avian Influenza H5N1 Virus Using the TideCell Bioreactor System Production of Avian Influenza H5N1 Virus Using the TideCell Bioreactor System www.bioreactorsciences.com A Production Case Study Using MDCK Cell Line Comparison Study Due to significant differences in

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTARY INFORMATION Viral vector vaccines expressing nucleoprotein and phosphoprotein genes of avian bornaviruses ameliorate homologous challenge infections in cockatiels and common canaries Marita

More information

Chang Gung University co-commissioned final report. Research Ttitle: Antiviral mechanism study for 254 UVC robot system

Chang Gung University co-commissioned final report. Research Ttitle: Antiviral mechanism study for 254 UVC robot system co-commissioned final report Research Ttitle: Antiviral mechanism study for 254 UVC robot system Project/Research Number:: Execution duration: 2014.10.16-2015.01.16 Principle Investigator: Professor Shin-Ru

More information

Influenza viruses are classified as members of the family

Influenza viruses are classified as members of the family Rewiring the RNAs of influenza virus to prevent reassortment Qinshan Gao a and Peter Palese a,b,1 Departments of a Microbiology and b Medicine, Mount Sinai School of Medicine, New York, NY 10029 Contributed

More information

Competing co-infections of LP and HP AIV H7N7

Competing co-infections of LP and HP AIV H7N7 Competing co-infections of LP and HP AIV H7N7 Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health Suedufer 10, 17493 Greifswald-Island of Riems, Germany Annika Graaf, Timm Harder

More information

The nonstructural (NS1) protein of influenza A virus is an antagonist

The nonstructural (NS1) protein of influenza A virus is an antagonist Mutations in the M-Gene Segment Can Substantially Increase Replication Efficiency of NS1 Deletion Influenza A Virus in MDCK Cells R. van Wielink, a,b M. M. Harmsen, a D. E. Martens b B. P. H. Peeters,

More information

Swine influenza surveillance among pigs in Nan Province

Swine influenza surveillance among pigs in Nan Province Swine influenza surveillance among pigs in Nan Province National Institute of Animal Health Department of Livestock Development Nan province 30 Aug 2011 การเฝ าระว งโรคไข หว ดใหญ ส กรในส กร จ งหว ดน าน

More information

1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal swine Influenza A vir

1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal swine Influenza A vir New Influenza A Virus Real Time RT-PCR Kit User Manual LT028310RRFY - 1 - 1. Intended Use New Influenza A virus real time RT-PCR Panel is used for the detection of universal influenza A virus, universal

More information

ICAAC/IDSA DC, Oct. 26, 2008

ICAAC/IDSA DC, Oct. 26, 2008 Tenofovir (TDF)- or Abacavir (ABC)-selected Minority Subpopulations in Viremic Subjects Detected by Ultra-deep Sequencing R. T. D Aquila 1, E. Rouse 2, J. Horton 2, A. Kheshti 1,3, S. Raffanti 1,3, K.

More information

Research Article Effect of the PB2 and M Genes on the Replication of H6 Influenza Virus in Chickens

Research Article Effect of the PB2 and M Genes on the Replication of H6 Influenza Virus in Chickens Influenza Research and Treatment, Article ID 547839, 6 pages http://dx.doi.org/10.1155/2014/547839 Research Article Effect of the PB2 and M Genes on the Replication of H6 Influenza Virus in Chickens Hiroichi

More information

Diagnostic Methods of HBV and HDV infections

Diagnostic Methods of HBV and HDV infections Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection

More information